SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?


To: Fitzhughlaw who wrote (45245)1/22/2018 12:09:17 PM
From: erickerickson3 Recommendations

Recommended By
erippetoe
ladyPI
rodneyh07

  Read Replies (1) | Respond to of 63276
 
Well, if those 10 companies pooled their funds into a single $140B package and offered it I'd be OK with a buyout ;)

Agreed, there's no buyout in the near future in my best-outcome scenario. If we speculate a bit though, someone mentioned VC attention spans of 3-5 years, so let's assume that for a thought experiment.

Let's imagine that IMMU continues to hit on all cylinders (and isn't that a weird thing to say). Given Dr T's comments on all the indications from a few days ago, a buyout price at the end of that time could be awesome.

Near-term, though I'll be happy with AA by late summer.

BTW, I now own my own tin-foil hat.... In fact I've put it over my entire house....



To: Fitzhughlaw who wrote (45245)1/22/2018 4:03:17 PM
From: samcat500  Read Replies (1) | Respond to of 63276
 
but IMMU has covered it's tail.. w/2020 vision (so to speak : )